Uganda Launches First Ebola Vaccine Trial Targeting Sudan Strain

The World Health Organization and Ugandan authorities are conducting a groundbreaking trial to combat the Sudan strain of Ebola following a recent outbreak in Kampala.

The World Health Organization (WHO) and Uganda's Ministry of Health have initiated the first-ever clinical trial for a vaccine targeting the Sudan strain of Ebola.
The trial follows a recent outbreak in Kampala that has killed one nurse and infected two of her relatives, with 234 contacts currently identified.
The vaccination uses a 'ring' strategy, prioritizing health workers and close contacts of confirmed cases to prevent further spread.
Over 2,000 doses of a candidate vaccine are available, though the manufacturer has not been disclosed, and the trial is being conducted at unprecedented speed during an emergency response.
This marks Uganda's sixth outbreak of the Sudan strain, a virus for which no approved vaccine exists, contrasting with licensed vaccines available for other Ebola species.